Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity
- 1 December 1997
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 158 (1), 19-27
- https://doi.org/10.1016/s0378-5173(97)00194-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Thermoanalysis of microspheresThermochimica Acta, 1995
- Circular dichroism studies of the self-association of amphotericin BChirality, 1994
- Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytesAntimicrobial Agents and Chemotherapy, 1992
- Drug targeting with polyalkylcyanoacrylate nanoparticles:in vitroactivity of primaquine-loaded nanoparticles against intracellularLeishmania donovaniPathogens and Global Health, 1992
- One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the mediumBiochemistry, 1991
- Effects of the detergent sucrose monolaurate on binding of amphotericin B to sterols and its toxicity for cellsBiochemical and Biophysical Research Communications, 1988
- A stability study of amphotericin B in aqueous media using factorial designInternational Journal of Pharmaceutics, 1988
- Microencapsulation of nitrofurantoin in poly(ϵ-caprolactone): tableting and in vitro release studiesInternational Journal of Pharmaceutics, 1987
- Structure of amphotericin B aggregates based on calculations of optical spectraPeptide Science, 1983
- Structure of amphotericin B aggregates as revealed by UV and CD spectroscopiesPeptide Science, 1981